Sign inJoin waitlistJoin the waitlist

MB

Michael Boyiadzis

Specialist

Credentials: ·

History

Hematology and Medical Oncology
Clinical Center at the National Institutes of Health
2001–2005
Internal Medicine
St Agnes HealthCare
1998–2001
Medical School
1991–1995

Research

DNMT3A and IDH mutations in acute myeloid leukemia and other myeloid malignancies: associations with prognosis and potential treatment strategies
Review · Leukemia · 2014 · Last of 7 authors · 219 citations
Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance
Review · Journal for ImmunoTherapy of Cancer · 2018 · First of 12 authors · 200 citations
Significance and implications of FDA approval of pembrolizumab for biomarker-defined disease
Review · Journal for ImmunoTherapy of Cancer · 2018 · First of 6 authors · 171 citations

AR
Anastasios Raptis
25 papers
JH
Jing-Zhou Hou
24 papers
MA
Mounzer Agha
24 papers
Robert Redner
20 papers
Annie Im
19 papers
Alison Sehgal
17 papers · 1 as a fellow
KD
Kathleen Dorritie
17 papers
RF
Rafic Farah
15 papers
Konstantinos Lontos
12 papers · 3 as a fellow
KF
Kenneth Foon
11 papers
Mark Litzow
8 papers
Steven Pavletic
7 papers